The abstract is read at the publisher; the summary is JClub's.
Hepatic sympathetic activity rises and hepatic sympathetic innervation diminishes as MASLD advances, linking altered hepatic neural balance to progression toward worse liver outcomes.
- Why it matters: Liver disease prevalence is extremely high, and mechanisms driving MASLD progression remain incompletely defined, limiting identification of causes and new treatment targets.
- What they did: This Review synthesizes findings from studies over the past 5 years on how hepatic nerves function and how metabolic disease modulates sympathetic and parasympathetic innervation, including links to fibrosis and dysfunction.
- The result: The evidence suggests hepatic neurons may influence progression of MASLD to metabolic dysfunction-associated steatohepatitis and hepatocellular carcinoma, and may be targetable for novel therapies.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.